Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment ... based drug delivery system that allows for the continuous release of gemcitabine chemotherapy ...

J&J acquired rights to the silicone-based drug delivery device ... In the case of TAR-200, it it is being used to deliver the chemotherapy agent gemcitabine. In a statement, J&J said that the ...

A recent study suggests that sequential intravesical treatment with gemcitabine and docetaxel is more effective than additional bacillus Calmette-Guérin (BCG) therapy for patients with BCG ...

Lastly, the company has initiated the submission of an original New Drug Application with the US Food and Drug Administration (FDA) for TAR-200 for the treatment of patients with Bacillus Calmette ...

As Forbes Vetted’s special projects editor and resident gifting expert, I did my research (and received bountiful blooms) to curate 12 of the best flower delivery services that truly satisfy ...

The high recurrence rate and the unpredictability of the progression pattern of bladder cancer have led to the widespread use of intravesical therapy as a supplement to TUR. Superficial bladder ...

The Billboard 200 is the United States’ main albums chart, compiled by Billboard magazine based on sales and streams in the USA. View the full Billboard 200 here.

TAR-200 Is Under Real-Time FDA Review for BCG-Unresponsive High-Risk NMIBC A new drug application for TAR-200, an intravesical drug system, is currently under review by the FDA to treat ...

If approved, the marketing authorization application would be valid in all 27 European Union member states as well as in Iceland, Liechtenstein, and Norway. "The three-year durability data from this ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.